{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:48:13Z","timestamp":1791589693167,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006331","name":"Cancerop\u00f4le PACA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004100","name":"Labex","doi-asserted-by":"publisher","award":["SIGNALIFE ANR-11- LABX-0028-01"],"award-info":[{"award-number":["SIGNALIFE ANR-11- LABX-0028-01"]}],"id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Foundation of France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.celrep.2024.115206","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T13:08:42Z","timestamp":1736514522000},"page":"115206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1585-8117","authenticated-orcid":false,"given":"Jean-Ehrland","family":"Ricci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2024.115206_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: Hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib4","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","article-title":"100 years of the Warburg effect: A cancer metabolism endeavor","volume":"187","author":"Fendt","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","article-title":"Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma","volume":"22","author":"Caro","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cmet.2019.02.002","article-title":"GAPDH Expression Predicts the Response to R-CHOP, the Tumor Metabolic Status, and the Response of DLBCL Patients to Metabolic Inhibitors","volume":"29","author":"Chiche","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","article-title":"Mechanisms and Implications of Metabolic Heterogeneity in Cancer","volume":"30","author":"Kim","year":"2019","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41389-022-00420-8","article-title":"Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance","volume":"11","author":"Vasseur","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.celrep.2024.115206_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1122789","article-title":"Orchestral role of lipid metabolic reprogramming in T-cell malignancy","volume":"13","author":"Mehta","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib10","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/2159-8290.CD-22-1220","article-title":"The DNA Damage Response and Inflammation in Cancer","volume":"13","author":"Klapp","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.celrep.2024.115206_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Frauwirth","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115206_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2024.115206_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2024.115206_bib17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00262-019-02457-y","article-title":"Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma","volume":"69","author":"Li","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2024.115206_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib20","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1073\/pnas.1913707117","article-title":"Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells","volume":"117","author":"P\u00fcschel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115206_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ccell.2019.07.008","article-title":"GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-kappaB-Dependent Mechanism","volume":"36","author":"Mondragon","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13046-024-02952-w","article-title":"Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment","volume":"43","author":"Krug","year":"2024","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.115206_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib24","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","article-title":"Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies","volume":"54","author":"Petrelli","year":"2015","journal-title":"Acta Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib25","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1016\/j.molcel.2023.09.034","article-title":"Lactate activates the mitochondrial electron transport chain independently of its metabolism","volume":"83","author":"Cai","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib26","first-page":"1464","article-title":"Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer","volume":"3","author":"Cappellesso","year":"2022","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.celrep.2024.115206_bib27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8(+) T\u00a0cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib28","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","article-title":"Lactate increases stemness of CD8\u00a0+ T\u00a0cells to augment anti-tumor immunity","volume":"13","author":"Feng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115206_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T\u00a0cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T\u00a0cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s13046-023-02845-4","article-title":"Amino acid metabolism reprogramming: shedding new light on T\u00a0cell anti-tumor immunity","volume":"42","author":"Zheng","year":"2023","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.115206_bib32","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41590-019-0495-x","article-title":"Quantitative analysis of T\u00a0cell proteomes and environmental sensors during T\u00a0cell differentiation","volume":"20","author":"Howden","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib33","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4049\/jimmunol.2200715","article-title":"Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8\u00a0T Cells","volume":"211","author":"Madden","year":"2023","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib35","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.cmet.2018.07.021","article-title":"Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting","volume":"28","author":"Alkan","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/s41586-023-06546-y","article-title":"Reductive carboxylation epigenetically instructs T\u00a0cell differentiation","volume":"621","author":"Jaccard","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj4857","article-title":"A blueprint for tumor-infiltrating B cells across human cancers","volume":"384","author":"Ma","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115206_bib38","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ni.3796","article-title":"alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib39","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1172\/JCI131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2024.115206_bib40","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1038\/s41467-024-47096-9","article-title":"Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies","volume":"15","author":"Daneshmandi","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115206_bib41","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.celrep.2017.07.054","article-title":"Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis","volume":"20","author":"Palmieri","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2024.115206_bib42","article-title":"Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A(+) myeloid cells to promote liver cancer progression","author":"Yang","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.celrep.2024.115206_bib43","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","article-title":"Asparagine restriction enhances CD8(+) T\u00a0cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response","volume":"5","author":"Gnanaprakasam","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celrep.2024.115206_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41556-020-00615-4","article-title":"Asparagine enhances LCK signalling to potentiate CD8(+) T-cell activation and anti-tumour responses","volume":"23","author":"Wu","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2024.115206_bib45","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib46","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s42255-024-01060-5","article-title":"ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response","volume":"6","author":"Lim","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celrep.2024.115206_bib47","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-14-1491","article-title":"l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells","volume":"75","author":"Fletcher","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2024.115206_bib48","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.1700600114","article-title":"Metabolic origins of spatial organization in the tumor microenvironment","volume":"114","author":"Carmona-Fontaine","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115206_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40425-019-0504-5","article-title":"Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity","volume":"7","author":"Miret","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2024.115206_bib50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccell.2016.09.009","article-title":"T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells","volume":"30","author":"Marigo","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1204506","article-title":"Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection","volume":"5","author":"Sektioglu","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2024.115206_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1240858","article-title":"The stress kinase GCN2 does not mediate suppression of antitumor T\u00a0cell responses by tryptophan catabolism in experimental melanomas","volume":"5","author":"Sonner","year":"2016","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celrep.2024.115206_bib53","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1128\/JVI.00994-16","article-title":"Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection","volume":"90","author":"Dagenais-Lussier","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2024.115206_bib54","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1182\/blood-2009-09-246124","article-title":"Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity","volume":"115","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.115206_bib55","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1078-0432.CCR-18-2882","article-title":"Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis","volume":"25","author":"Labadie","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.115206_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102461","article-title":"Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy","volume":"110","author":"Fujiwara","year":"2022","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.celrep.2024.115206_bib57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","article-title":"Methionine metabolism in health and cancer: a nexus of diet and precision medicine","volume":"19","author":"Sanderson","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celrep.2024.115206_bib58","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/s42255-023-00857-0","article-title":"Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target","volume":"5","author":"Vande Voorde","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celrep.2024.115206_bib59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-020-2682-1","article-title":"Cancer SLC43A2 alters T\u00a0cell methionine metabolism and histone methylation","volume":"585","author":"Bian","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib60","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1038\/s41467-023-40345-3","article-title":"A bimetallic nanoplatform for STING activation and CRISPR\/Cas mediated depletion of the methionine transporter in cancer cells restores anti-tumor immune responses","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115206_bib61","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2024.115206_bib62","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/s42255-023-00854-3","article-title":"Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota","volume":"5","author":"Ji","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celrep.2024.115206_bib63","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJM197505222922107","article-title":"The clinical pharmacology of antineoplastic agents (first of two parts)","volume":"292","author":"Chabner","year":"1975","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib65","first-page":"333","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.celrep.2024.115206_bib66","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1078-0432.CCR-18-1844","article-title":"Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL","volume":"25","author":"Touzart","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2024.115206_bib67","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41571-023-00804-8","article-title":"A new era for glioma therapy - targeting mutant IDH","volume":"20","author":"Reardon","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib68","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.abj5104","article-title":"Oncometabolite d-2HG alters T\u00a0cell metabolism to impair CD8(+) T\u00a0cell function","volume":"377","author":"Notarangelo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115206_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl6173","article-title":"Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity","volume":"385","author":"Wu","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115206_bib70","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/ERC-22-0030","article-title":"Preclinical evaluation of targeted therapies in Sdhb-mutated tumors","volume":"29","author":"Moog","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.celrep.2024.115206_bib71","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.euo.2019.11.002","article-title":"Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals","volume":"3","author":"Forde","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib72","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/1878-0261.13583","article-title":"Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759","volume":"18","author":"Pujalte-Martin","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib73","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-023-06299-8","article-title":"SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity","volume":"620","author":"Guo","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib74","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib75","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T\u00a0cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) T\u00a0cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.celrep.2024.115206_bib77","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","article-title":"Obesity induces PD-1 on macrophages to suppress anti-tumour immunity","volume":"630","author":"Bader","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2024.115206_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00262-024-03735-0","article-title":"Inhibition of glycolysis enhances the efficacy of immunotherapy via PDK-mediated upregulation of PD-L1","volume":"73","author":"Zhang","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2024.115206_bib79","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-1426-2-3","article-title":"Mechanism of tumor rejection with doublets of CTLA-4, PD-1\/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T\u00a0cells directly within the tumor microenvironment","volume":"2","author":"Spranger","year":"2014","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2024.115206_bib80","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.2018.78.9602","article-title":"Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I\/II Trial (ECHO-202\/KEYNOTE-037)","volume":"36","author":"Mitchell","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib81","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib82","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1158\/1535-7163.MCT-20-0430","article-title":"The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies","volume":"20","author":"Varghese","year":"2021","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.celrep.2024.115206_bib83","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41591-019-0564-6","article-title":"Clinical lessons learned from the first leg of the CAR T\u00a0cell journey","volume":"25","author":"Majzner","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T\u00a0cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1470-2045(18)30864-7","article-title":"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial","volume":"20","author":"Locke","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib86","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","article-title":"The mitochondrial pyruvate carrier regulates memory T\u00a0cell differentiation and antitumor function","volume":"34","author":"Wenes","year":"2022","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib87","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/0008-5472.CAN-14-2277","article-title":"Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics","volume":"75","author":"Crompton","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2024.115206_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb8969","article-title":"Metabolic reprogramming of donor T\u00a0cells enhances graft-versus-leukemia effects in mice and humans","volume":"12","author":"Uhl","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib89","article-title":"Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies","volume":"11","author":"Lopez","year":"2023","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.celrep.2024.115206_bib90","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","article-title":"Metformin Enhances the Antitumor Activity of CD8(+) T Lymphocytes via the AMPK-miR-107-Eomes-PD-1 Pathway","volume":"204","author":"Zhang","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2024.115206_bib91","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1073\/pnas.1920413117","article-title":"Lactate dehydrogenase inhibition synergizes with IL-21 to promote CD8(+) T\u00a0cell stemness and antitumor immunity","volume":"117","author":"Hermans","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2024.115206_bib92","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/s42255-024-01034-7","article-title":"Extracellular domains of CARs reprogramme T\u00a0cell metabolism without antigen stimulation","volume":"6","author":"Lakhani","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.celrep.2024.115206_bib93","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/1878-0261.13691","article-title":"Metabolic dialogues: regulators of chimeric antigen receptor T\u00a0cell function in the tumor microenvironment","volume":"18","author":"Moraly","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib94","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2023.12.010","article-title":"Mitochondrial isocitrate dehydrogenase impedes CAR T\u00a0cell function by restraining antioxidant metabolism and histone acetylation","volume":"36","author":"Si","year":"2024","journal-title":"Cell Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib95","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2024.115206_bib96","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2014-10-608133","article-title":"Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in\u00a0vivo","volume":"125","author":"Miraki-Moud","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2024.115206_bib97","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/annonc\/mdy101","article-title":"Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma","volume":"29","author":"Abou-Alfa","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib98","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib99","first-page":"731","article-title":"FDA approves IDH1 and IDH2 inhibitor for brain cancer","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.celrep.2024.115206_bib100","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.celrep.2024.115206_bib101","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1470-2045(20)30157-1","article-title":"Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2024.115206_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn6491","article-title":"Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression","volume":"8","author":"Grima-Reyes","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2024.115206_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101294","article-title":"Physiological impact of in\u00a0vivo stable isotope tracing on cancer metabolism","volume":"53","author":"Grima-Reyes","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.celrep.2024.115206_bib104","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3427","article-title":"Isolation and Quantification of Metabolite Levels in Murine Tumor Interstitial Fluid by LC\/MS","volume":"9","author":"Sullivan","year":"2019","journal-title":"Bio. Protoc."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724015572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124724015572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:23:14Z","timestamp":1781554994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124724015572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":104,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2211124724015572"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115206","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2024.115206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115206"}}